Equity · Healthcare
DHR
NYSEDanaher (DHR)
The line runs 197.56 USD on 3 August through 223 USD on 13 October, on a scale from 190 to 230. Days the market did not trade hold the previous close, flat.
- Market cap
- 156.9B USD
- P/E (TTM)
- 36.4
- Revenue, year to Dec 2025
- 24.6B USD
- EPS, diluted, year to Dec 2025
- 5.05 USD
- 52-week range
- 161.92 USD – 242 USD
- Avg volume
- 247.8K
as of Oct 13, 2026
Have Danaher (DHR) insiders bought or sold shares recently?
In the 90 days to 1 Nov 2026, Danaher insiders reported 3 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 31 Oct 2025, show no open-market purchase.
Form 4, 90 days to 1 Nov 2026, newest reported trade 28 Oct 2026
Buys 0Sells 3Net sold $21.53MOther filings 9
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 28 Oct 2026 | Bouda ChristopherVP, Chief Accounting Officer | Sell | 7,598 | 1.8M USD |
| 28 Oct 2026 | McGrew MatthewExecutive Vice President | Sell | 29,754 | 7.0M USD |
| 21 Aug 2026 | Blair RainerPresident & CEO | Sell | 58,255 | 12.7M USD |
| Sold | 3 open-market sales | 95,607 | $21.53M |
9 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 28 Oct 2026 | Bouda ChristopherVP, Chief Accounting Officer | Option exercise | 7,598 | 537K USD |
| 28 Oct 2026 | McGrew MatthewExecutive Vice President | Option exercise | 15,603 | 1.2M USD |
| 09 Oct 2026 | RALES MITCHELL PChairman of Exec. Committee | Other | 500,000 | |
| 09 Oct 2026 | RALES STEVEN MChairman | Other | 500,000 | |
| 04 Aug 2026 | Milosevich Gregory MExecutive Vice President | Award | 15,402 | |
| 04 Aug 2026 | Gutierrez-Ramos Jose-CarlosSVP, Chief Science Officer | Award | 13,477 | |
| 04 Aug 2026 | Riley Christopher PaulExecutive Vice President | Award | 41,072 | |
| 04 Aug 2026 | RALES MITCHELL PChairman of Exec. Committee | Award | 500,000 | |
| 04 Aug 2026 | RALES STEVEN MChairman | Award | 500,000 |
Which funds hold Danaher (DHR)?
20 of the 45 institutional funds we track reported a Danaher position for the quarter ended 30 Jun 2026 — a combined 3.4B USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Held (±25%) | 4,484,774 | 854.3M USD | −2.6% |
| AQR Capital Management | Held (±25%) | 2,641,746 | 503.2M USD | −24.1% |
| D1 Capital Partners | Held (±25%) | 2,282,039 | 434.7M USD | −1.0% |
| Millennium Management | Added | 2,140,587 | 407.7M USD | +1,070.8% |
| Glenview Capital Management | Added | 1,145,979 | 218.3M USD | +633.3% |
| Citadel Advisors | Held (±25%) | 943,694 | 179.8M USD | −8.1% |
| Renaissance Technologies | Held (±25%) | 760,636 | 144.9M USD | +12.1% |
| Balyasny Asset Management | Added | 759,207 | 144.6M USD | +282.3% |
| Third Point | Held (±25%) | 540,000 | 102.9M USD | +2.9% |
| Tiger Global Management | New position | 456,000 | 86.9M USD |
Showing the 10 largest of 20 reported positions. The figures above count all of them.
Have members of Congress traded Danaher (DHR)?
The most recent congressional trade disclosed in Danaher is a sale by Kevin Hern (house, OK), dated 02 Sep 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 02 Sep 2026 | Kevin Hernhouse · Republican–OK | Sale | 1K USD–15K USD | 23 days |
| 18 Dec 2025 | Julie Johnsonhouse · Democrat–TX | Sale | 1K USD–15K USD | 28 days |
| 13 Nov 2025 | Julie Johnsonhouse · Democrat–TX | Sale | 1K USD–15K USD | 28 days |
| 07 Oct 2025 | Julie Johnsonhouse · Democrat–TX | Purchase | 1K USD–15K USD | 38 days |
| 25 Sep 2025 | Lisa C. McClainhouse · Republican–MI | Sale | 1K USD–15K USD | 27 days |
| 03 Sep 2025 | Thomas H. Kean, Jr.house · Republican–NJ | Purchase | 1K USD–15K USD | 41 days |
| 22 Jul 2025 | Lisa C. McClainhouse · Republican–MI | Purchase | 1K USD–15K USD | 22 days |
| 11 Jun 2025 | Thomas H. Kean, Jr.house · Republican–NJ | Purchase | 1K USD–15K USD | 35 days |
Danaher (DHR) US federal contracts
US federal agencies committed 126.0M USD in contracts to Danaher (DHR) in fiscal 2026, the year to 30 Sep 2026, against 127.9M USD the year before.
USAspending.gov
Fiscal 2027 so far 35.5M USDFiscal 2026 126.0M USDFiscal 2025 127.9M USDFiscal 2024 148.6M USD
| Signed | Agency | Contract | Committed |
|---|---|---|---|
| 28 Oct 2026 | Office of the Chief Financial OfficerDepartment of Agriculture | CENTRIFUGE MAINTENANCE SERVICESMAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT · 124PSA27F0002 · BECKMAN COULTER, INC. | 143K USD |
| 26 Oct 2026 | Department of Veterans Affairs | CEPHEID GENEXPERT MAINTENANCEMAINT/REPAIR/REBUILD OF EQUIPMENT- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES · 36C24227N0184 · CEPHEID | 172K USD |
| 20 Oct 2026 | Department of Veterans Affairs | EXPRESS REPORT: NX ORDERS PLACED FOR THE MONTH OF SEPTEMBER 2026LABORATORY EQUIPMENT AND SUPPLIES · 36C10X27K0077 · LEICA MICROSYSTEMS INC. | 164K USD |
| 16 Oct 2026 | Department of Veterans Affairs | CEPHEIDIN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS · 36C24227N0172 · CEPHEID | 584K USD |
| 15 Oct 2026 | Department of Veterans Affairs | MOD - CEPHEID REAGENTS CONTRACT - MODIFICATION TO ADD 52.222-90IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS · 36C25727N0093 · CEPHEID | 1.6M USD |
| 13 Oct 2026 | Department of Veterans Affairs | PCR MOLECULAR SYSTEM - COLUMBIA AND KC VAMCS - OPTION YEAR FOURLABORATORY EQUIPMENT AND SUPPLIES · 36C25527N0003 · CEPHEID | 184K USD |
| 08 Oct 2026 | Department of Veterans Affairs | CEPHEID REAGENTSLABORATORY EQUIPMENT AND SUPPLIES · 36C25027P0036 · CEPHEID | 446K USD |
| 05 Oct 2026 | Department of Veterans Affairs | MICRO MOLECULAR COST PER TEST & 2 LEASED ANALYZERSLABORATORY EQUIPMENT AND SUPPLIES · 36C24827P0005 · CEPHEID | 561K USD |
| 02 Oct 2026 | Department of Veterans Affairs | TASK ORDERIN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS · 36C24127N0074 · CEPHEID | 281K USD |
| 02 Oct 2026 | Department of Veterans Affairs | TASK ORDERIN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS · 36C24127N0073 · CEPHEID | 110K USD |
Newest first: 10 of 980 contracts. Contracts of US$100,000 or more signed since April 2022; the amount is what the government has committed so far, which grows when options are exercised. Defense Department contracts are published about 90 days after signing, so the latest year is still filling in.
What has been filed or recorded for Danaher (DHR)?
The filings we hold for Danaher, newest first: 8 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 2,335 shares | 520K USD notional · <0.001% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 17 shares | 4K USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 585 shares | 127K USD notional · <0.001% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 7 shares | 2K USD notional · <0.001% of shares out |
| 01 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,230 shares | 273K USD notional · <0.001% of shares out |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 1,610 shares | 361K USD notional · <0.001% of shares out |
| 25 Sep 2026 | Fails to deliver | Shares failed to deliver | 117,928 shares | 26.4M USD notional · 0.017% of shares out |
| 25 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 1.75 USD | |
| 25 Sep 2026 | Financials | Total assets | 93.3B USD | at period end |
| 25 Sep 2026 | Financials | Total equity | 53.6B USD | at period end |
| 21 Sep 2026 | Fails to deliver | Shares failed to deliver | 100 shares | 21K USD notional · <0.001% of shares out |
| 26 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 1.23 USD | |
| 27 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 1.45 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 5.05 USD | |
| 31 Dec 2025 | Financials | Revenue | 24.6B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 3.6B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 5.05 USD | fiscal year |
| 26 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 1.27 USD | |
| 27 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.77 USD | |
| 28 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 1.32 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 5.29 USD |
Danaher (DHR): frequently asked questions
What did Danaher shares close at?
Danaher closed at 223.00 USD on 13 Oct 2026, up 0.90% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Danaher’s market cap?
Danaher is worth 156.9B USD by market value as of 13 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is Danaher’s P/E ratio?
Danaher has a price-to-earnings ratio of 36.4, as of 13 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Danaher’s revenue?
Danaher reported revenue of 24.6B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Danaher insiders bought or sold shares recently?
In the 90 days to 1 Nov 2026, Danaher insiders reported 3 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 31 Oct 2025, show no open-market purchase. A further 9 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Danaher?
20 of the 45 funds we track reported a Danaher position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Fisher Asset Management, AQR Capital Management and D1 Capital Partners. See Funds
Have members of Congress traded Danaher?
Yes. 49 trades in Danaher appear in the congressional disclosures we hold; the latest is a sale by Kevin Hern (House, OK) dated 2 Sep 2026, filed 25 Sep 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Danaher last report earnings?
Danaher last reported earnings on 25 Sep 2026 for Q3 2026, with EPS of 1.75 USD; no next date is announced in SEC filings yet. See Filings
Does Danaher have government contracts?
Yes. US federal agencies committed 126.0M USD in contracts to it in fiscal 2026, the year to 30 Sep 2026 (USAspending.gov). See Contracts
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- USAspendingUSAspending.gov (U.S. Department of the Treasury), federal prime contract awards
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 25 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Danaher_Corporation